Latest Breaking News On - Bristol myers squibb sustiva - Page 1 : comparemela.com

John C. Martin, 69, Dies; Led Drugmaker in Breakthroughs A chemist by training, he turned Gilead Sciences into a leading, and lucrative, innovator with single-pill treatments for H.I.V. and hepatitis C. John C. Martin in 2006 with a bottle of Truvada, a groundbreaking treatment for H.I.V. made by his company, Gilead Sciences, in the Bay Area. Credit.Paul Sakuma/Associated Press April 27, 2021, 6:43 p.m. ET John C. Martin, who became a billionaire by developing and marketing a daily single-dose pill that transformed H.I.V. into a manageable disease and who popularized another drug that cures hepatitis C, died on March 30 in Palo Alto, Calif. He was 69.

Purdue universityUnited statesPalo altoSanta clara countyFoster cityGolden gate universitySan franciscoJohn milliganBristol myers squibb sustivaJohnc martinTellis alexander martinBristol myers squibbRosemary carellaJohn charles martinInternational society for antiviral researchJohnc martin foundation